Atika Capital Management LLC Takes Position in Acadia Healthcare Company, Inc. $ACHC

Atika Capital Management LLC bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 122,600 shares of the company's stock, valued at approximately $2,868,000. Atika Capital Management LLC owned about 0.13% of Acadia Healthcare as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Aberdeen Group plc grew its holdings in Acadia Healthcare by 72.3% during the 4th quarter. Aberdeen Group plc now owns 743,925 shares of the company's stock valued at $10,556,000 after buying an additional 312,172 shares in the last quarter. Louisiana State Employees Retirement System purchased a new position in shares of Acadia Healthcare in the first quarter valued at $957,000. SG Americas Securities LLC grew its holdings in shares of Acadia Healthcare by 717.8% in the fourth quarter. SG Americas Securities LLC now owns 292,425 shares of the company's stock valued at $4,150,000 after purchasing an additional 256,669 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new stake in Acadia Healthcare during the fourth quarter valued at $2,838,000. Finally, FourThought Financial Partners LLC bought a new position in Acadia Healthcare during the fourth quarter valued at $325,000.

Analyst Upgrades and Downgrades

ACHC has been the subject of several recent research reports. Guggenheim lifted their price target on Acadia Healthcare from $26.00 to $31.00 and gave the stock a "buy" rating in a research report on Monday, May 4th. UBS Group raised their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 9th. KeyCorp lifted their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a report on Tuesday, July 14th. Raymond James Financial raised Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. Finally, Barclays increased their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Thursday, April 30th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $28.69.

Acadia Healthcare Trading Down 2.2%

Shares of NASDAQ ACHC opened at $34.01 on Friday. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83. The business has a fifty day moving average price of $27.46 and a 200 day moving average price of $23.10. The stock has a market capitalization of $3.13 billion, a P/E ratio of -2.78, a price-to-earnings-growth ratio of 11.60 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same period in the previous year, the company earned $0.40 earnings per share. The business's revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.